Simplify Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,519
Closed -$505K 121
2023
Q3
$505K Sell
11,519
-131
-1% -$6.39K 0.06% 94
2023
Q2
$575K Buy
11,650
+2,882
+33% +$133K 0.08% 88
2023
Q1
$363K Sell
8,768
-2,620
-23% -$109K 0.05% 95
2022
Q4
$505K Buy
11,388
+917
+9% +$38.3K 0.08% 56
2022
Q3
$409K Buy
10,471
+3,275
+46% +$150K 0.04% 56
2022
Q2
$294K Sell
7,196
-3,458
-32% -$164K 0.01% 60
2022
Q1
$700K Buy
10,654
+5,324
+100% +$345K 0.02% 50
2021
Q4
$371K Buy
+5,330
New +$387K 0.02% 56

Other funds holding ATRC

Simplify Asset Management's ATRC Position: Q4 2023 in Review

Simplify Asset Management sold out of AtriCure (ATRC) in Q4 2023, closing a stake of 11,519 shares — an estimated $505K sold.

Simplify Asset Management first reported a position in ATRC in Q4 2021 and held it in 8 quarters. The position peaked at $700K in Q1 2022. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

  • Simplify Asset Management reported no remaining AtriCure position as of Q4 2023 after selling out during the quarter.
  • Simplify Asset Management sold 11,519 AtriCure shares in Q4 2023, an estimated $505K.
  • Simplify Asset Management first reported a position in AtriCure in Q4 2021 and held it in 8 quarters.
  • Simplify Asset Management's AtriCure position peaked at $700K in Q1 2022.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on Simplify Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.